Macitentan (ACT-064992) is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)[1].
Molecular Weight:
588.27
Purity:
99.87
CAS Number:
[441798-33-0]
Formula:
C19H20Br2N6O4S
Target:
Apoptosis,Endothelin Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
